Hospira Recalls Quelicin Injection Due to Faded or Missing Label Dates
Hospira Inc. is recalling 103,600 vials of Quelicin (Succinylcholine Chloride) Injection because the lot number or expiration date may be faded or missing from the primary label.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard is limited to a labeling defect (faded or missing dates) without reported injuries or illnesses.
Plain-English summary
Hospira Inc. is recalling 103,600 vials of Quelicin (Succinylcholine Chloride) Injection, USP 200 mg (20 mg/mL), 10 mL Multiple-dose vial. The product is distributed nationwide and is identified by Lot 52-045-EV with an expiration date of 07/1/2016.
The recall was initiated due to a labeling defect where the lot number and/or expiration date may be faded or missing from the primary label on the glass vial. This issue could potentially affect the ability to verify the specific lot and expiration status of the medication.
Healthcare providers and facilities should check their inventory for this specific lot and expiration date. If the product is found, it should be removed from use and returned to Hospira Inc. according to their instructions.
The recalled product
- Product
- QUELICIN (SUCCINYLCHOLINE CHLORIDE)
- Brand
- QUELICIN
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 103,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 52-045-EV
- Exp 07/1/2016
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · QUELICIN
- SevereHospira Recalls Quelicin Injection Due to Lack of Sterility Assurance
FDA (Drugs) · 2017-08-09
- SevereHospira Recalls QUELICIN Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-15
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02